Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab
Tatsuki Ikoma, Mototsugu Shimokawa, Toshihiko Matsumoto, Shogen Boku, Tomoyo Yasuda, Nobuhiro Shibata, Yusuke Kurioka, Masahiro Takatani, Tetsuji Nobuhisa, Tsutomu Namikawa, Hiroyuki Kitagawa, Kazuhiro Hanazaki, Keitaro Doi, Takanobu Shimada, Takehiko Tsumura, Hiroyuki Marusawa, Seichiro Kanaya, Shuko Morita, Tetsurou Inokuma, Hiroki Nagai, Hisateru Yasui, Hironaga Satake
Topics & Concepts
MedicineNivolumabInternal medicineHazard ratioGastroenterologyConfidence intervalOncologyEsophageal squamous cell carcinomaCarcinomaCancerImmunotherapyEsophageal Cancer Research and TreatmentInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and Biomarkers